Sen. Sheldon Whitehouse sold Biogen (BIIB)
Sen. Sheldon Whitehouse (D-RI) · $1K–$15K · traded Jan 8, 2018
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Jan 8, 2018
- Disclosed
- Feb 13, 2018
- Days to disclose
- 36
- Asset type
- Stock
- As filed
- Biogen Inc.
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
- Feb 13, 2018$15K–$50K
$15K–$50K · Traded Jan 31, 2018 · disclosed Feb 13, 2018 · Joint
- Feb 13, 2018$1K–$15K
$1K–$15K · Traded Jan 17, 2018 · disclosed Feb 13, 2018
- Feb 13, 2018$1K–$15K
$1K–$15K · Traded Jan 17, 2018 · disclosed Feb 13, 2018
- Feb 13, 2018$15K–$50K
Sold (full) Costco Wholesale COST
$15K–$50K · Traded Jan 17, 2018 · disclosed Feb 13, 2018 · Joint
- Feb 13, 2018$1K–$15K
$1K–$15K · Traded Jan 17, 2018 · disclosed Feb 13, 2018 · Joint
- Feb 13, 2018$1K–$15K
$1K–$15K · Traded Jan 8, 2018 · disclosed Feb 13, 2018 · Spouse
- Feb 13, 2018$1K–$15K
$1K–$15K · Traded Jan 8, 2018 · disclosed Feb 13, 2018 · Spouse
Recent Congress trades in BIIB
- Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 9, 2026 · Dependent
- Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Oct 8, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded Sep 24, 2026 · disclosed Oct 8, 2026
- Sep 2, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
$1K–$15K · Traded Aug 18, 2026 · disclosed Sep 2, 2026
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 8, 2026$15K–$50K
Rep. Maria Elvira Salazar (R-FL-27)
$15K–$50K · Traded Jun 2, 2026 · disclosed Jul 8, 2026
- Jul 3, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Jun 5, 2026 · disclosed Jul 3, 2026
- Jun 9, 2026$1K–$15K
Rep. Maria Elvira Salazar (R-FL-27)
$1K–$15K · Traded May 12, 2026 · disclosed Jun 9, 2026
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.